NYSE:WST - West Pharmaceutical Services Stock Price, Forecast & News

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services announced a quarterly dividend on Tuesday, December 17th. Stockholders of record on Wednesday, January 22nd will be paid a dividend of $0.16 per share on Wednesday, February 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Tuesday, January 21st. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.15. View West Pharmaceutical Services' Dividend History.

West Pharmaceutical Services Inc. (NYSE:WST) released its quarterly earnings results on Thursday, February, 13th. The medical instruments supplier reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.72 by $0.10. The medical instruments supplier had revenue of $470.60 million for the quarter, compared to analyst estimates of $451.53 million. West Pharmaceutical Services had a net margin of 13.14% and a return on equity of 17.06%. West Pharmaceutical Services's quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.73 EPS. View West Pharmaceutical Services' Earnings History.

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April 23rd 2020. View Earnings Estimates for West Pharmaceutical Services.

West Pharmaceutical Services issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.40. The company issued revenue guidance of $1.95-1.97 billion, compared to the consensus revenue estimate of $1.95 billion.

3 brokerages have issued 1-year target prices for West Pharmaceutical Services' shares. Their forecasts range from $112.16 to $135.00. On average, they expect West Pharmaceutical Services' stock price to reach $123.05 in the next year. This suggests that the stock has a possible downside of 27.7%. View Analyst Price Targets for West Pharmaceutical Services.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

News articles about WST stock have trended negative this week, according to InfoTrie. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a news impact score of -2.2 on InfoTrie's scale. They also gave news headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for West Pharmaceutical Services.

West Pharmaceutical Services saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 1,020,000 shares, a drop of 23.9% from the January 15th total of 1,340,000 shares. Based on an average daily trading volume, of 452,100 shares, the days-to-cover ratio is presently 2.3 days. Currently, 1.4% of the company's stock are sold short. View West Pharmaceutical Services' Current Options Chain.

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include PepsiCo (PEP), Johnson & Johnson (JNJ), Mcdonald's (MCD), Medtronic (MDT), AbbVie (ABBV), Lowe's Companies (LOW), Walmart (WMT), NVIDIA (NVDA), AFLAC (AFL) and PPG Industries (PPG).

West Pharmaceutical Services' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (6.01%), State Street Corp (3.70%), Bamco Inc. NY (2.01%), Capital Research Global Investors (1.94%), WCM Investment Management LLC (1.81%) and Artisan Partners Limited Partnership (1.49%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

WST stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Bamco Inc. NY, Cubist Systematic Strategies LLC, Schroder Investment Management Group, Victory Capital Management Inc., Victory Capital Management Inc., USS Investment Management Ltd and Intermede Investment Partners Ltd. View Insider Buying and Selling for West Pharmaceutical Services.

WST stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Renaissance Technologies LLC, Alliancebernstein L.P., Bank of Montreal Can, Swiss National Bank and Point72 Asset Management L.P.. View Insider Buying and Selling for West Pharmaceutical Services.

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WST stock can currently be purchased for approximately $170.16.

West Pharmaceutical Services has a market capitalization of $12.59 billion and generates $1.84 billion in revenue each year. The medical instruments supplier earns $241.70 million in net income (profit) each year or $3.24 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]